15.1  0.02 (0.13%)		05-22 16:00
Open: 15.2 High: 15.37 Volume: 73,227		Pre. Close: 15.08 Low: 15.0199 Market Cap: 592(M)

Short term
Mid term
Targets	6-month :	18.99	1-year :	20.26
Resists	First :	16.26	Second :	17.35
Pivot price	15.96
Supports	First :	14.5	Second :	12.06
MAs	MA(5) :	15.04	MA(20) :	16.06
	MA(100) :	13.32	MA(250) :	9.67
MACD	MACD :	0	Signal :	0.2
%K %D	K(14,3) :	22.9	D(3) :	19.1
RSI	RSI(14): 44.8
52-week	High :	17.35	Low :	5

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ BWAY ] has closed above bottom band by 22.4%. Bollinger Bands are 21.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	15.38 - 15.45	15.45 - 15.52
Low:	14.83 - 14.92	14.92 - 15
Close:	14.96 - 15.09	15.09 - 15.22

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

Fri, 22 May 2026
BWAY SEC Filings - Brainsway Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan

Thu, 21 May 2026
Brainsway (BWAY) director exercises 27,500 options, uses 9,520 shares for tax - Stock Titan

Tue, 19 May 2026
BrainsWay Announces Minority-Stake Investment in Hopemark Health - Sahm

Mon, 18 May 2026
BrainsWay (BWAY) Secures Strategic Financing Agreement for Growt - GuruFocus

Mon, 18 May 2026
BrainsWay backs Chicago-area mental health clinics with $1.5M stake - Stock Titan

Thu, 14 May 2026
BrainsWay Ltd. (NASDAQ:BWAY) Q1 2026 Earnings Call Transcript - Insider Monkey

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	40 (M)
Shares Float	27 (M)
Held by Insiders	6 (%)
Held by Institutions	29.9 (%)
Shares Short	121 (K)
Shares Short P.Month	99 (K)

EPS	0.18
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	1.87
Profit Margin	15.5 %
Operating Margin	12.9 %
Return on Assets (ttm)	3.3 %
Return on Equity (ttm)	12.5 %
Qtrly Rev. Growth	34.5 %
Gross Profit (p.s.)	1.06
Sales Per Share	1.4
EBITDA (p.s.)	0.16
Qtrly Earnings Growth	200 %
Operating Cash Flow	14 (M)
Levered Free Cash Flow	3 (M)

PE Ratio	83.88
PEG Ratio	0
Price to Book value	8.07
Price to Sales	10.75
Price to Cash Flow	44.29

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.